Login / Signup

Proarrhythmic potential of metoclopramide in a sensitive whole-heart model.

Julian WolfesChristian EllermannSophie BurdeMichael FehrLars EckardtGerrit Frommeyer
Published in: Basic & clinical pharmacology & toxicology (2021)
This is the first experimental study that investigated the effect of increasing doses of metoclopramide on a sensitive whole-heart model of proarrhythmia. MCP led to a significant increase in action potential duration and QT interval; meanwhile, the number of ventricular tachycardias was significantly increased.
Keyphrases
  • heart failure
  • atrial fibrillation
  • left ventricular
  • human health
  • high resolution